Shares of Amgen Inc. AMGN inched 0.24% higher to $264.00 Monday, on what proved to be an all-around favorable trading session ...

The latest trading day saw Amgen (AMGN) settling at $264, representing a +0.24% change from its previous close.

Amgen Inc (AMGN) stock saw a modest uptick, ending the day at $263.38 which represents a slight increase of $2.19 or 0.84% from the prior close of $261.19. The stock opened at $269 and touched a low ...

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...

A look at the shareholders of BeiGene, Ltd. ( NASDAQ:BGNE) can tell us which group is most powerful. With 45% stake, institutions possess the maximum shares in the company. That is, the group stands ...

The study met its main goal, but those watching closely had hoped for an average result of at least 25% weight loss.

Major League Baseball, active rosters expand to 28 players. 4-7 _ Men’s golf, DP World Tour, The Amgen Irish Open, Kildare, Ireland. 4-14 _ Boxing, World Boxing Championship, Liverpool, England. 5-7 _ ...

The strategy involves buying the 10 highest-yielding stocks in the Dow Jones Industrial Average., holding them for a year, ...

The Schwab US Dividend Equity ETF (NYSE:SCHD) has given back more than half of its one-year gains in the last month, with the ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...

Amgen has won FDA approval for a stronger label for its oral plaque psoriasis therapy Otezla, as it prepares for competition from Bristol-Myers Squibb's much-touted rival deucravacitinib ...